Prostate cancer trials in China

In China 252 Also abroad 1481

252 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
A Trial to Evaluate the Effect of Applying Leukapheresis to Enrich CTCs in mPCa Patients
Where
Shanghai
Age
18 years to 75 years
People
50
Run by
RenJi Hospital
See details and how to joinNCT06469710
Phase 1Taking people
A Phase I Clinical Study of HLX3902 in Patients With mCRPC and Other Advanced Tumours
Where
Nanchang, Naning, Nanjing, Shanghai, Xiamen
Age
18 years and over
People
48
Run by
Shanghai Henlius Biotech
See details and how to joinNCT07533708
No phaseTaking people
miRNA Panel for PCa Diagnosis
Where
Shanghai
Age
18 years and over
People
500
Run by
RenJi Hospital
See details and how to joinNCT07755592
No phaseEnrolling by invitation
Plasma Exosome RNA to Diagnose Prostate Cancer
Where
Lanzhou, Weinan, Xi'an, Xianyang, Xining, Yan’an, Yinchuan
Age
18 years and over
People
1,600
Run by
Xijing Hospital
See details and how to joinNCT06604130
No phaseTaking people
Extraperitoneal SINgle-port rObotic-assisted Radical Prostatectomy (RARP) Versus Transperitoneal Multi-port RARP in the Treatment Of Prostate Cancer (SINO-TOP)
Where
Shanghai
Age
18 years to 75 years
People
480
Run by
Shanghai Changzheng Hospital
See details and how to joinNCT06238713
Phase 2/3Not yet taking people in China
A Study of BL-B01D1 Combination Therapy in Patients With Metastatic Castration-resistant Prostate Cancer
Where
Beijing, Shanghai
Age
18 years and over
People
180
Run by
Sichuan Baili Pharmaceutical Co., Ltd.
See details and how to joinNCT07641855
Phase 2Taking people
Adjuvant Rezvilutamide Monotherapy for High-Risk Prostate Cancer After Radical Prostatectomy
Where
Nanjing
Age
18 years to 75 years
People
48
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07711314
No phaseTaking people
Development of an AI-Agent for Urological Disease Diagnosis and Treatment
Where
Ganzhou, Guangzhou, Shantou
People
2,000
Run by
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT07721935
No phaseTaking people
Large Language Model-Assisted cTNM Annotation From Chinese PSMA PET/CT Reports
Where
Wenzhou
Age
18 years and over
People
4,600
Run by
First Affiliated Hospital of Wenzhou Medical University
See details and how to joinNCT07707232
No phaseTaking people
MRI-DTI Assessment of Urethral Internal Sphincter Ring and Prostate Base Morphology
Where
Taizhou
Age
15 years to 90 years
People
80
Run by
Jiangsu Taizhou People's Hospital
See details and how to joinNCT07694752
Phase 1/2Taking people
A Clinical Study of [68Ga]Ga-ELI421 Injection PET Imaging in Patients With Prostate Cancer
Where
Wuhan
Age
18 years to 80 years
People
50
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07689656
No phaseNot yet taking people in China
Infrared Fluorescence Staining Versus Frozen Section for Prostate Cancer Surgery
Where
Changsha
Age
18 years and over
People
120
Run by
Xiangya Hospital of Central South University
See details and how to joinNCT07690462
Phase 4Not yet taking people in China
177Lu-PSMA-617 Combined With Darolutamide in Neoadjuvant Treatment of High-risk Localized Prostate Cancer: a Prospective, Single-arm, Multi-center Clinical Trial
Where
Nanjing
Age
18 years to 75 years
People
20
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07677566
Phase 1Taking people
Clinical Evaluation of 177Lu-PSMA-VG01 Injection in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer （mCRPC）
Where
Shanghai
Age
18 years to 80 years
People
10
Run by
VitsGen Therapeutics Inc.
See details and how to joinNCT07660211
No phaseEnrolling by invitation
AI-based Prediction of Prostate Cancer Metastasis Using Biopsy Pathology
Where
Changsha
Age
18 years to 90 years
People
3,000
Run by
Xiangya Hospital of Central South University
See details and how to joinNCT07660276
Phase 3Taking people
Radiotherapy After Prostatectomy for Node Positive Prostate Cancer
Where
Beijing, Chengdu, Dongguan, Guangzhou, Hangzhou, Shanghai, Zhanjiang, Zhengzhou
Age
18 years and over
People
372
Run by
Sun Yat-sen University
See details and how to joinNCT07477626
No phaseTaking people
Optimizing Prostate Biopsy Schemes in Men With Multiple MRI Visible Lesions
Where
Beijing
Age
18 years to 85 years
People
572
Run by
Peking University First Hospital
See details and how to joinNCT06841211
Phase 1Taking people
Dual-target PSMA/PSCA CAR-NK Cells in Advanced Prostate Cancer
Where
Shenzhen
Age
18 years and over
People
36
Run by
Beijing Biotech
See details and how to joinNCT07641049
Phase 2Not yet taking people in China
A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.
Where
Beijing, Harbin
Age
18 years to 80 years
People
227
Run by
GV20 Therapeutics
See details and how to joinNCT07623642
Phase 1/2Taking people
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer
Where
Beijing, Changsha, Foshan, Fuzhou, Hangzhou, Hubei, Ji'nan, Nanchang, Nanjing, Shanghai, Shenyang, Tianjin, Wenzhou, Zhengzhou
Age
18 years and over
People
84 worldwide
Run by
Shenzhen Ionova Life Sciences Co., Ltd.
See details and how to joinNCT06609005
Phase 1/2Taking people
A Clinical Study of QLC5508 and/or QLH12016 in Combination With Other Anti-tumor Therapies in Subjects With Advanced Prostate Cancer
Where
Tianjin
Age
18 years and over
People
212
Run by
Qilu Pharmaceutical Co., Ltd.
See details and how to joinNCT07198633
Phase 2/3Taking people
Trop2-targeted immunoPET Imaging of Solid Tumors
Where
Shanghai
Age
18 years to 75 years
People
400
Run by
RenJi Hospital
See details and how to joinNCT06851663
Phase 1/2Taking people
A Study of TRC003 in the Treatment of Patients With Progressive PSMA-positive mCRPC
Where
Shanghai, Taiyuan
Age
18 years and over
People
90
Run by
C Ray Therapeutics
See details and how to joinNCT07567521
No phaseTaking people
Multimodal Imaging and Digital Pathology for Prostate Cancer Prediction
Where
Liuzhou
Age
40 years to 90 years
People
3,000
Run by
Guangxi Medical University
See details and how to joinNCT07614256
No phaseTaking people
PSMA PET/MRI-Guided Prostate Biopsy for PI-RADS ≤3 and Prior Negative Biopsy
Where
Fuzhou
Age
30 years to 85 years
People
230
Run by
First Affiliated Hospital of Fujian Medical University
See details and how to joinNCT06923657